Skip to content

Covid-19-associated research on hand eczema in the health sector – Part 1

Covid-19-associated research on hand eczema in the health sector – Part 1 - CARE+

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00022957
Enrollment
260
Registered
2020-10-07
Start date
2020-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L20-L30

Interventions

Group 1: 130 employees in nursing professions receive health education training on the pathogenesis and prevention of (occupational) hand eczema and are provided with suitable skin cleansing and skin

Sponsors

Institut für interdisziplinäre dermatologische Prävention und Rehabilitation an der Universität Osnabrück (iDerm)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Presence of a signed declaration of consent - of legal age - Nursing profession in health care/nursing care or stationary geriatric care (e.g. geriatric nurse, geriatric nursing assistant, specialist for nursing assistance, health and nursing care, health and nursing care assistants/state certified nursing care assistants).

Exclusion criteria

Exclusion criteria: Known allergy to fragrances or oatmeal (IG only).

Design outcomes

Secondary

MeasureTime frame
Optimization of skin protection and skin care behavior.

Primary

MeasureTime frame
Maintenance of a good skin condition or improvement of existing skin changes on the hands. Examination (OHSI-Score) of the hands conducted by a dermatologist at T1 (after 3 months) [optional at T1, according to the current state of the pandemic] and T2 (after 6 months), survey of the participants with standardised questionnaires at T1 and T2.

Countries

Germany

Contacts

Public ContactCara Symanzik

Institut für interdisziplinäre dermatologische Prävention und Rehabilitation an der Universität Osnabrück (iDerm)

csymanzik@uos.de0541 9696 2357

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026